Julie Pannequin Selected Research

beta Catenin

11/2007

Beta-catenin/Tcf-4 inhibition after progastrin targeting reduces growth and drives differentiation of intestinal tumors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Julie Pannequin Research Topics

Disease

19	Neoplasms (Cancer) 12/2022 - 07/2002
17	Colorectal Neoplasms (Colorectal Cancer) 12/2022 - 12/2002
5	Colonic Neoplasms (Colon Cancer) 12/2022 - 05/2014
4	Neoplasm Metastasis (Metastasis) 12/2021 - 01/2018
3	Carcinogenesis 02/2012 - 11/2007
2	Circulating Neoplastic Cells 12/2021 - 10/2021
2	Adenoma (Adenomas) 11/2007 - 11/2007
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2018
1	Liver Cell Adenoma (Hepatocellular Adenoma) 09/2014
1	Hepatocellular Carcinoma (Hepatoma) 09/2014
1	Adenocarcinoma 05/2014
1	Hyperplasia 11/2007
1	Adenomatous Polyposis Coli (Familial Adenomatous Polyposis) 11/2007
1	Urinary Bladder Neoplasms (Bladder Cancer) 02/2007
1	Carcinoma (Carcinomatosis) 02/2007
1	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 01/2004
1	Carcinoid Tumor (Carcinoid) 12/2002
1	Astrocytoma (Pilocytic Astrocytoma) 07/2002

Drug/Important Bio-Agent (IBA)

4	Small Interfering RNA (siRNA)IBA 12/2021 - 11/2007
3	Fluorouracil (Carac)FDA LinkGeneric 10/2022 - 07/2017
3	Proteins (Proteins, Gene)FDA Link 01/2021 - 02/2007
3	Pharmaceutical PreparationsIBA 01/2018 - 04/2015
3	big gastrinIBA 01/2016 - 11/2007
2	Pregnane X ReceptorIBA 12/2022 - 08/2016
2	MicroRNAs (MicroRNA)IBA 12/2022 - 07/2017
2	Messenger RNA (mRNA)IBA 10/2022 - 05/2014
2	Phosphotransferases (Kinase)IBA 01/2022 - 01/2018
2	SuspensionsIBA 12/2021 - 01/2016
2	Biological ProductsIBA 01/2021 - 07/2002
2	Metformin (Glucophage)FDA LinkGeneric 01/2018 - 01/2018
2	CopperIBA 01/2018 - 01/2018
2	Claudin-2IBA 01/2018 - 02/2010
2	Biomarkers (Surrogate Marker)IBA 08/2016 - 02/2010
2	CateninsIBA 05/2014 - 02/2012
2	GastrinsIBA 11/2007 - 07/2002
1	ElementsIBA 12/2022
1	Niclosamide FDA Link 12/2022
1	src-Family KinasesIBA 01/2022
1	Tyrosine (L-Tyrosine)FDA Link 01/2022
1	ProteomeIBA 01/2022
1	RNA (Ribonucleic Acid)IBA 12/2021
1	DNA (Deoxyribonucleic Acid)IBA 12/2021
1	Epithelial Cell Adhesion MoleculeIBA 10/2021
1	sortilinIBA 01/2021
1	AntibodiesIBA 01/2021
1	Alpha-Ketoglutarate-Dependent Dioxygenase FTOIBA 01/2021
1	Tight Junction ProteinsIBA 01/2018
1	CollagenIBA 01/2018
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2018
1	nilotinib FDA Link 01/2018
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2018
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 08/2016
1	Penicillins (Penicillin)FDA Link 01/2016
1	Streptomycin (Streptomycin Sulfate)FDA Link 01/2016
1	Peptides (Polypeptides)IBA 01/2016
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2016
1	Etoposide (VP 16)FDA LinkGeneric 04/2015
1	LuciferasesIBA 09/2014
1	Nuclear Receptor Interacting Protein 1IBA 05/2014
1	ArrestinsIBA 02/2012
1	Jagged-1 ProteinIBA 08/2009
1	beta CateninIBA 11/2007
1	Glycine (Aminoacetic Acid)FDA LinkGeneric 11/2007
1	Ethanol (Ethyl Alcohol)IBA 11/2007
1	rat Ybx3 proteinIBA 11/2007
1	phosphatidylethanolIBA 11/2007
1	Claudin-4IBA 02/2007
1	ClaudinsIBA 02/2007
1	Protein Isoforms (Isoforms)IBA 02/2007
1	TransferasesIBA 02/2007
1	SaltsIBA 01/2004
1	BismuthIBA 01/2004
1	glycine-extended gastrin 17IBA 12/2002
1	gastrin 17 (G 17)IBA 12/2002

Therapy/Procedure

6	Therapeutics 01/2021 - 11/2007
4	Drug Therapy (Chemotherapy) 12/2022 - 08/2016
1	Subcutaneous Injections 12/2021
1	Precision Medicine 12/2021
1	Radiotherapy 01/2021